drugset / Trial / NCT00720369
CoQ10 in Geriatric Bipolar Depression
Completed
42 enrolled
Mclean Hospital
National Alliance for Research on Schizophrenia and Depression · collab
Non-randomizedParallel-groupOpen-labelBasic science
Summary
We propose to study and compare measures of brain energy metabolism in geriatric bipolar individuals and healthy older adults. We would also like to investigate changes in brain energy metabolites and in vivo creatine kinase (CK) enzymatic activity associated with CoQ10 administration in older bipolar individuals.
Timeline
- Start
- 2008-07
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme Q10 | Other / unclassified | 400 mg | Oral |
| Subject | Coenzyme Q10 | Other / unclassified | 1200 mg | Oral |